This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Medical Practice  • Law and Medicine  • Public Health, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Mike Mitka

JAMA. 2008;299(10):1124.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A Government Accountability Office (GAO) report shows that the US Food and Drug Administration (FDA) has not met its statutory requirement for inspections every 2 years of US manufacturers of such high-risk medical devices as pacemakers.

In the report, presented at a January 29 hearing before the House Committee on Energy and Commerce's Subcommittee on Oversight and Investigations, the GAO said the FDA estimates that it inspects manufacturers of high-risk devices every 3 years and those producing medium-risk devices (such as hearing aids) every 5 years. And while there is no comparable requirement for inspecting plants outside the United States, the FDA estimated that it inspects foreign manufacturers of high-risk devices every 6 years and those making medium-risk devices every 27 years (http://www.gao.gov/new.items/d08428t.pdf).

The subcommittee also received a report from the FDA's Science Board, an advisory panel that reports directly to the agency's commissioner, that said . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?